Cargando…
Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
PURPOSE: The approach to the use of generic antiepileptic drugs has recently evolved from major concern to general acceptance, but the evidence related specifically to the safety of switching from brand-name to generic levetiracetam (LEV) is scarce. The aim of the study was to assess the risk of inc...
Autores principales: | Bosak, Magdalena, Słowik, Agnieszka, Turaj, Wojciech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546726/ https://www.ncbi.nlm.nih.gov/pubmed/28814836 http://dx.doi.org/10.2147/DDDT.S138270 |
Ejemplares similares
-
Menstrual disorders and their determinants among women with epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2018) -
COVID-19 among patients with epilepsy: Risk factors and course of the disease
por: Bosak, Magdalena, et al.
Publicado: (2021) -
Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023) -
Appearances of Premature Atrial and Ventricular Contractions After Switching From Brand Name to Generic Cibenzoline
por: Oguri, Gaku, et al.
Publicado: (2023) -
The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013)